Real estate stocks are experiencing a downturn, extending losses for the third consecutive session due to concerns about slowing demand and profit-taking after a significant rally. The realty index has underperformed the Nifty, with several key stocks like Godrej Properties and DLF seeing notable declines. Analysts anticipate potential further drops amid sluggish demand and strong...Read More

Continuum Green Energy Holdings will acquire the remaining 26% stake from Clean Energy Investing (CEIL), marking Morgan Stanley Infrastructure Partners’ exit after a decade. This acquisition consolidates control under founders Vikash Saraf and Arvind Bansal ahead of Continuum’s planned ₹3,650 crore IPO. The IPO proceeds will be used for debt repayment, general corporate purposes, and...Read More

TruAlt Bioenergy, an Indian biofuels producer, is set to launch its IPO to raise ₹750 crore for expansion and working capital, alongside an ₹89 crore offer for sale. While the company benefits from the growing ethanol and biogas demand, it faces policy risks. Financials show strong revenue and profit growth, but also increased debt.Read More

Mumbai bond market awaits the government’s borrowing calendar. Traders are cautious before the monetary policy review. They anticipate details on the Centre’s H2 borrowing. The market expects changes in long-term bond issuance. RBI’s reallocation strategy is also under scrutiny. Experts suggest measures to address yield curve distortions. The focus is on rebalancing the borrowing calendar.Read More

Markets declined due to global and domestic pressures, with the Nifty testing support at 25040. Glenmark Pharma partnered with Hengrui Pharma, while Adani Energy Solutions achieved ‘Zero-Waste-to-Landfill’ certification. Poly Medicure will acquire Citieffe Group, and Dr Reddy’s and Hetero Labs will sell generic HIV prevention drugs. Tata Motors faced supplier payment issues due to a...Read More

Indian equities faced a fourth consecutive losing session, influenced by US visa policy concerns and persistent foreign investor selling. While festive demand and GST reforms offer support, currency weakness and global headwinds, including India-US trade deal uncertainty, are expected to keep markets range-bound. Technically, the 25,000-25,050 zone is crucial support; a fall below could trigger...Read More

Indian pharmaceutical and healthcare firms are set for a significant fundraising push, aiming to garner ₹12,000-13,000 crore through IPOs in the coming months. Approximately fifteen companies are expected to enter the primary market, with fertility and women’s health segments particularly in focus.Read More

Quadria Capital is exploring options to sell its stake in Encube Ethicals. The healthcare investor considers both a controlling stake sale and an IPO. Encube Ethicals, a dermatology firm, is valued at $2.2 billion. KKR, Blackstone, and EQT show interest in acquiring a stake. JP Morgan is already mandated for the sale.Read More

Quest Global, the engineering services outsourcing firm, is planning a pre-IPO funding round aiming for a valuation between $3 billion and $3.5 billion. The company intends to sell a 5-6% stake, seeking $200-$225 million from a new investor, involving both primary and secondary share sales.Read More

JSW Group plans to raise funds for acquiring AkzoNobel India. The group will issue non-convertible debentures to raise ₹7,000 crore. JTPM Metal Traders will handle the issuance. The bonds have a tenure of four years and seven months. They offer an IRR of 8.5%. The NCDs are backed by corporate guarantees from JSW Group entities.Read More